SGH
PACB icon

Schonfeld Group Holdings’s Pacific Biosciences PACB Stock Holding History

Schonfeld Group Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$347K Buy
+26,427
New +$237K 0.22% 141

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schonfeld Group Holdings's PACB Position: Q4 2015 in Review

Schonfeld Group Holdings opened a new position in Pacific Biosciences (PACB) in Q4 2015: 26,427 shares worth $347K. The stake represents 0.22% of the portfolio and ranks #141 among its holdings.

119 funds tracked by Wall St. Rank hold PACB as of Q4 2015.

  • Schonfeld Group Holdings held 26,427 shares of Pacific Biosciences worth $347K as of Q4 2015.
  • Pacific Biosciences was a new Schonfeld Group Holdings position in Q4 2015.
  • Pacific Biosciences made up 0.22% of Schonfeld Group Holdings's portfolio in Q4 2015, its #141 holding.
  • 119 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.